Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
This is a first-in-man, phase I clinical research study with BKM120, a potent and highly specific oral pan-class I phosphatidylinositol-3-kinase (PI3K) inhibitor. The study consists of a dose escalation part followed by a MTD expansion part. Once the MTD has been defined, the MTD expansion part will be opened for enrollment.
Inclusion criteria
- Breast Cancer,colon cancer,Ovarian Cancer,Endometrium Cancer